Altfest L J & CO Inc Alnylam Pharmaceuticals, Inc. Transaction History

Altfest L J & CO Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$143.31 - $247.0 $1,719 - $2,964	12 Added 0.57%	2,112 $513,000
Q1 2024 Apr 22, 2024	BUY	$146.51 - $198.2 $3,955 - $5,351	27 Added 1.3%	2,100 $314,000
Q4 2023 Jan 18, 2024	BUY	$151.41 - $196.57 $71,919 - $93,370	475 Added 29.72%	2,073 $397,000
Q3 2023 Oct 26, 2023	BUY	$170.77 - $211.65 $83,506 - $103,496	489 Added 44.09%	1,598 $283,000
Q2 2023 Aug 09, 2023	SELL	$185.01 - $212.05 $3,330 - $3,816	-18 Reduced 1.6%	1,109 $211,000
Q1 2023 Apr 20, 2023	SELL	$182.66 - $235.53 $2,009 - $2,590	-11 Reduced 0.97%	1,127 $226,000
Q4 2022 Feb 02, 2023	SELL	$185.53 - $241.31 $7,050 - $9,169	-38 Reduced 3.23%	1,138 $270,000
Q3 2022 Nov 15, 2022	SELL	$138.54 - $232.0 $56,939 - $95,352	-411 Reduced 25.9%	1,176 $235,000
Q2 2022 Aug 04, 2022	SELL	$120.42 - $169.29 $2,167 - $3,047	-18 Reduced 1.12%	1,587 $231,000
Q1 2022 May 02, 2022	BUY	$127.18 - $173.91 $204,123 - $279,125	1,605 New	1,605 $262,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Altfest L J & CO Inc with notifications on news.